Joint assessment of the uric acid-to-HDL cholesterol ratio and the triglyceride-glucose index for predicting incident metabolic syndrome in Chinese adults aged 45 years and older: a prospective cohort study based on CHARLS
This prospective cohort study of 3,550 Chinese adults aged 45 and older demonstrates that the uric acid-to-HDL cholesterol ratio and the triglyceride-glucose index independently predict incident metabolic syndrome, with their joint assessment providing a statistically significant, albeit modest, improvement in predictive accuracy over conventional risk factors.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Metabolic syndrome is a cluster of health problems that often travel together: excess weight around the middle, high blood pressure, trouble with blood sugar, and an imbalance of fats in the blood. When these conditions appear together, they significantly raise the risk of heart disease and type 2 diabetes. For decades, doctors have looked for early warning signs to catch this syndrome before it fully develops. Two biological pathways are known to drive these issues. One involves a state of low-grade inflammation and oxidative stress, which damages cells and disrupts how the body handles energy. The other involves insulin resistance, where the body's cells stop responding properly to insulin, the hormone that regulates sugar. While scientists have long studied these pathways separately, a new question has emerged: does looking at both at the same time give a clearer picture of who is at risk?
Researchers from Sun Yat-sen Memorial Hospital in China set out to answer this question using a large, long-term study of Chinese adults. They focused on two specific measurements that can be calculated from standard blood tests already taken during routine checkups. The first measurement, called the uric acid-to-HDL cholesterol ratio, compares a substance that can promote inflammation with a type of cholesterol that protects blood vessels. A higher ratio suggests a body under more inflammatory stress. The second measurement, known as the triglyceride-glucose index, combines levels of fat and sugar in the blood to estimate how well the body is handling insulin. Neither test requires extra blood draws or special equipment; they are simply new ways of looking at numbers doctors already have. The researchers wanted to see if combining these two signals could predict who would develop metabolic syndrome over the next four years better than looking at either signal alone or relying on traditional risk factors like age and body weight.
The study followed 3,550 adults aged 45 and older who did not have metabolic syndrome at the start. These participants were part of a national survey that tracks the health and retirement of Chinese citizens. The researchers measured their blood levels in 2011 and checked again in 2015 to see who had developed the condition. They divided the participants into four groups based on whether their inflammation ratio and their insulin-resistance index were high or low. The results showed a clear pattern. People who had high levels of both markers were much more likely to develop metabolic syndrome than those with low levels of both. Specifically, the group with both high markers had more than three times the risk of developing the syndrome compared to the group with low levels of both.
When the researchers looked at the two markers individually, both were important. For every standard increase in the inflammation ratio, the risk went up by about 40 percent. For every standard increase in the insulin-resistance index, the risk went up by about 50 percent. However, the study found that the insulin-resistance index was the stronger driver when separating people into groups. The most striking finding was that adding both of these measurements to a standard risk assessment improved the ability to predict who would get sick. While the improvement was modest, it was statistically significant and consistent. The new combination of markers helped reclassify many people into more accurate risk categories, identifying high-risk individuals who might otherwise have been missed by looking at body weight or age alone.
The researchers also investigated whether the two markers worked together in a way that created a sudden, explosive risk, or if their effects simply added up. The data suggested the latter. The risk for people with both high markers was roughly what you would expect if you added the risks of each marker together, rather than a massive spike caused by a complex interaction between them. This implies that the two pathways—inflammation and insulin resistance—are running in parallel, each contributing its own burden to the body's health. The study also found that this pattern held true across different groups of people, regardless of whether they were men or women, smokers or non-smokers, or living in cities or rural areas.
A crucial aspect of the findings is that this high-risk signal does not depend on a person being overweight. The group with the highest risk had an average body mass index that fell within the normal range. This suggests that relying solely on weight to screen for metabolic risk misses a significant number of people who are metabolically unhealthy. Because the two markers used in the study come from routine blood tests that are already standard in many medical checkups, they offer a practical, no-cost way to identify these hidden risks. The study concludes that checking both the inflammation ratio and the insulin-resistance index together provides a more complete view of metabolic health than either one alone, offering a simple tool to help doctors spot trouble before it becomes a full-blown disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.